Akansha Trivedi @Akatri: "𝙈𝙖𝙧𝙠𝙚𝙩 𝙋𝙪𝙡𝙡𝙗𝙖𝙘𝙠, 𝙉𝙤𝙫𝙤 𝙉𝙤𝙧𝙙𝙞𝙨𝙠 𝙀𝙖𝙧𝙣𝙞𝙣𝙜𝙨..."

Germany

𝙈𝙖𝙧𝙠𝙚𝙩 𝙋𝙪𝙡𝙡𝙗𝙖𝙘𝙠, 𝙉𝙤𝙫𝙤 𝙉𝙤𝙧𝙙𝙞𝙨𝙠 𝙀𝙖𝙧𝙣𝙞𝙣𝙜𝙨 & 𝙉𝙚𝙬 𝘼𝙙𝙙𝙞𝙩𝙞𝙤𝙣𝙨 Dear Investors, Hello to all new copiers and followers — welcome aboard! Markets cooled slightly yesterday after a strong October run. This pause came as investors digested the Fed’s rate cut and shifting bond yields — a normal, healthy part of any market cycle. Pullbacks like these aren’t red flags; they’re natural resets that often create opportunities for disciplined investors to add capital or start copying strategies they believe in. 𝙉𝙤𝙫𝙤 𝙉𝙤𝙧𝙙𝙞𝙨𝙠 𝙀𝙖𝙧𝙣𝙞𝙣𝙜𝙨 $NVO (Novo-Nordisk A/S SPONS ADR) reported another strong quarter, with GLP-1 drug sales (Ozempic, Wegovy) driving double-digit revenue growth and solid margin expansion. However, the stock saw mild pressure as expectations had been extremely high. The core business remains robust, and the company continues to dominate one of the fastest-growing therapeutic markets globally. Strong fundamentals, temporary valuation fatigue — not structural weakness. 𝙋𝙤𝙧𝙩𝙛𝙤𝙡𝙞𝙤 𝙐𝙥𝙙𝙖𝙩𝙚𝙨 We’ve opened small new positions in: Palantir $PLTR (Palantir Technologies Inc.) – Expanding exposure to AI-driven software that’s now demonstrating tangible profitability, strong U.S. government demand, and commercial traction beyond hype. It’s a long-term data-infrastructure play, not a momentum trade. Arista Networks $ANET (Arista Networks Inc) – Adding exposure to enterprise and cloud networking infrastructure — the “picks and shovels” of AI growth. Exceptional balance sheet, consistent earnings beats, and leverage to hyperscaler CAPEX cycles make it a strategic addition. Both are fundamentally profitable AI enablers, unlike many speculative peers. Always REMEMBER, 𝙑𝙤𝙡𝙖𝙩𝙞𝙡𝙞𝙩𝙮 𝙞𝙨 𝙣𝙚𝙫𝙚𝙧 𝙩𝙝𝙚 𝙚𝙣𝙚𝙢𝙮 — 𝙚𝙢𝙤𝙩𝙞𝙤𝙣 𝙞𝙨. We stay grounded in data, diversification, and process — because long-term conviction outperforms short-term reaction. Thank you for your continued trust — let’s keep building with discipline. Best @Akatri $NSDQ100 $GOLD